AAAAAA

   
Results: 1-17 |
Results: 17
Interleukin-8 receptor (CXCR2) antagonists
Authors: Sarau, HM Widdowson, KL Palovich, MR White, JR Underwood, DC Griswold, DE
Citation: Hm. Sarau et al., Interleukin-8 receptor (CXCR2) antagonists, PROG R RES, 31, 2001, pp. 293-296
Inhibition of p38 MAP kinase
Authors: Underwood, DC Griswold, DE
Citation: Dc. Underwood et De. Griswold, Inhibition of p38 MAP kinase, PROG R RES, 31, 2001, pp. 342-345
A synthesis of studies on the intellectual, academic, social/emotional andsensory characteristics of children and youth with Asperger syndrome
Authors: Myles, BS Barnhill, GP Hagiwara, T Griswold, DE Simpson, RL
Citation: Bs. Myles et al., A synthesis of studies on the intellectual, academic, social/emotional andsensory characteristics of children and youth with Asperger syndrome, EDUC TRAIN, 36(3), 2001, pp. 304-311
Pyrimidinylimidazole inhibitors of p38: Cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity
Authors: Adams, JL Boehm, JC Gallagher, TF Kassis, S Webb, EF Hall, R Sorenson, M Garigipati, R Griswold, DE Lee, JC
Citation: Jl. Adams et al., Pyrimidinylimidazole inhibitors of p38: Cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity, BIOORG MED, 11(21), 2001, pp. 2867-2870
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung
Authors: Underwood, DC Osborn, RR Bochnowicz, S Webb, EF Rieman, DJ Lee, JC Romanic, AM Adams, JL Hay, DWP Griswold, DE
Citation: Dc. Underwood et al., SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung, AM J P-LUNG, 279(5), 2000, pp. L895-L902
Inhibition of p38 MAP kinase as a therapeutic strategy
Authors: Lee, JC Kumar, S Griswold, DE Underwood, DC Votta, BJ Adams, JL
Citation: Jc. Lee et al., Inhibition of p38 MAP kinase as a therapeutic strategy, IMMUNOPHARM, 47(2-3), 2000, pp. 185-201
Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice
Authors: Griswold, DE Douglas, SA Martin, LD Davis, TG Davis, L Ao, ZH Luttmann, MA Pullen, M Nambi, P Hay, DWP Ohlstein, EH
Citation: De. Griswold et al., Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice, J CARDIO PH, 36, 2000, pp. S78-S81
Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist
Authors: Sarau, HM Griswold, DE Bush, B Potts, W Sandhu, P Lundberg, D Foley, JJ Schmidt, DB Webb, EF Martin, LD Legos, JJ Whitmore, RG Barone, FC Medhurst, AD Luttmann, MA Giardina, GAM Hay, DWP
Citation: Hm. Sarau et al., Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist, J PHARM EXP, 295(1), 2000, pp. 373-381
SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence
Authors: Underwood, DC Osborn, RR Kotzer, CJ Adams, JL Lee, JC Webb, EF Carpenter, DC Bochnowicz, S Thomas, HC Hay, DWP Griswold, DE
Citation: Dc. Underwood et al., SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence, J PHARM EXP, 293(1), 2000, pp. 281-288
Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation
Authors: Davis, HM Carpenter, DC Stahl, JM Zhang, WY Hynicka, WP Griswold, DE
Citation: Hm. Davis et al., Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation, J IMMUNOL M, 240(1-2), 2000, pp. 125-132
Identification and initial characterization of four novel members of the interleukin-1 family
Authors: Kumar, S McDonnell, PC Lehr, R Tierney, L Tzimas, MN Griswold, DE Capper, EA Tal-Singer, R Wells, GI Doyle, ML Young, PR
Citation: S. Kumar et al., Identification and initial characterization of four novel members of the interleukin-1 family, J BIOL CHEM, 275(14), 2000, pp. 10308-10314
Inhibition of contact sensitivity in human CD4(+) transgenic mice by humanCD4-specific monoclonal antibodies: CD4(+) T-cell depletion is not required
Authors: Podolin, PL Webb, EF Reddy, M Truneh, A Griswold, DE
Citation: Pl. Podolin et al., Inhibition of contact sensitivity in human CD4(+) transgenic mice by humanCD4-specific monoclonal antibodies: CD4(+) T-cell depletion is not required, IMMUNOLOGY, 99(2), 2000, pp. 287-295
Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis
Authors: Badger, AM Griswold, DE Kapadia, R Blake, S Swift, BA Hoffman, SJ Stroup, GB Webb, E Rieman, DJ Gowen, M Boehm, JC Adams, JL Lee, JC
Citation: Am. Badger et al., Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis, ARTH RHEUM, 43(1), 2000, pp. 175-183
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity
Authors: Sarau, HM Foley, JJ Schmidt, DB Martin, LD Webb, EF Tzimas, MN Breton, JJ Chabot-Fletcher, M Underwood, DC Hay, DWP Kingsbury, WD Chambers, PA Pendrak, I Jakas, DR Sathe, GM Van Horn, S Daines, RA Griswold, DE
Citation: Hm. Sarau et al., In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity, PROS LEUK E, 61(1), 1999, pp. 55-64
Endothelin B receptor modulates inflammatory pain and cutaneous inflammation
Authors: Griswold, DE Douglas, SA Martin, LD Davis, TG Davis, L Ao, ZH Luttmann, MA Pullen, M Nambi, P Hay, DWP Ohlstein, EH
Citation: De. Griswold et al., Endothelin B receptor modulates inflammatory pain and cutaneous inflammation, MOLEC PHARM, 56(4), 1999, pp. 807-812
Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis
Authors: Badger, AM Blake, SM Dodds, RA Griswold, DE Swift, BA Rieman, DJ Stroup, GB Hoffman, SJ Gowen, M
Citation: Am. Badger et al., Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis, J PHARM EXP, 291(3), 1999, pp. 1380-1386
Pyrimidinylimidazole inhibitors of CSBP/P37 kinase demonstrating decreasedinhibition of hepatic cytochrome P450 enzymes
Authors: Adams, JL Boehm, JC Kassis, S Gorycki, PD Webb, EF Hall, R Sorenson, M Lee, JC Ayrton, A Griswold, DE Gallagher, TF
Citation: Jl. Adams et al., Pyrimidinylimidazole inhibitors of CSBP/P37 kinase demonstrating decreasedinhibition of hepatic cytochrome P450 enzymes, BIOORG MED, 8(22), 1998, pp. 3111-3116
Risultati: 1-17 |